- Home
- ASO vs SRRK Comparison
ASO vs SRRK Comparison
Compare ASO & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASO
- SRRK
- Stock Information
- Founded
- ASO 1938
- SRRK 2012
- Country
- ASO United States
- SRRK United States
- Employees
- ASO N/A
- SRRK N/A
- Industry
- ASO Recreational Games/Products/Toys
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASO Consumer Discretionary
- SRRK Health Care
- Exchange
- ASO Nasdaq
- SRRK Nasdaq
- Market Cap
- ASO 3.1B
- SRRK 2.9B
- IPO Year
- ASO 2020
- SRRK 2018
- Fundamental
- Price
- ASO $37.85
- SRRK $30.75
- Analyst Decision
- ASO Buy
- SRRK Strong Buy
- Analyst Count
- ASO 17
- SRRK 6
- Target Price
- ASO $59.18
- SRRK $42.17
- AVG Volume (30 Days)
- ASO 2.3M
- SRRK 1.6M
- Earning Date
- ASO 06-10-2025
- SRRK 05-06-2025
- Dividend Yield
- ASO 1.38%
- SRRK N/A
- EPS Growth
- ASO N/A
- SRRK N/A
- EPS
- ASO 5.73
- SRRK N/A
- Revenue
- ASO $5,933,450,000.00
- SRRK N/A
- Revenue This Year
- ASO $4.93
- SRRK N/A
- Revenue Next Year
- ASO $7.21
- SRRK $601.05
- P/E Ratio
- ASO $6.61
- SRRK N/A
- Revenue Growth
- ASO N/A
- SRRK N/A
- 52 Week Low
- ASO $33.34
- SRRK $6.76
- 52 Week High
- ASO $64.62
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- ASO 39.37
- SRRK 49.04
- Support Level
- ASO $36.14
- SRRK $28.79
- Resistance Level
- ASO $38.00
- SRRK $31.09
- Average True Range (ATR)
- ASO 3.11
- SRRK 2.50
- MACD
- ASO -0.21
- SRRK 0.44
- Stochastic Oscillator
- ASO 30.98
- SRRK 78.82
About ASO Academy Sports and Outdoors Inc.
Academy Sports and Outdoors Inc is engaged in the full-line sporting goods and outdoor recreation retailer in the United States. The company's product categories are outdoors, apparel, sports & recreation, and footwear.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.